Immunotherapy in head and neck squamous cell carcinoma: An updated review

Immunotherapy in head and neck squamous cell carcinoma: An updated review

Squamous cell cancer of the head and neck (HNSCC) is the sixth most common cancer and is associated with significant morbidity and mortality. The tumor microenvironment for HNSCC is a complex interplay of immune cells, stromal cells, and cytokines amongst others. Immunotherapy acts as an effective a...

Full description

Bibliographic Details
Main Authors: K. Parmar, A. Mohamed, E. Vaish, R. Thawani, J. Cetnar, K.Z. Thein
Format: Article
Language:English
Published: Elsevier 2022-01-01
Series:Cancer Treatment and Research Communications
Subjects:
Immunotherapy
Pembrolizumab
Nivolumab
Head and neck squamous cell carcinoma
Tumor microenvironment
Immune and stromal cells
Online Access:http://www.sciencedirect.com/science/article/pii/S246829422200140X

Internet

http://www.sciencedirect.com/science/article/pii/S246829422200140X

Similar Items